Valuation (21%) |
Company | Industry |
---|---|---|
P/E Ratio (TTM) | -0.21 | N/A |
PEG Ratio (TTM) | -0.07 | N/A |
P/S Ratio (TTM) | 0.46 | N/A |
P/B Ratio (TTM) | 1.07 | N/A |
P/FCF Ratio (TTM) | -1.00 | N/A |
Price to 5YR AVG Earnings Ratio | -0.24 | N/A |
Price to 5YR AVG FCF Ratio | -0.67 | N/A |
Profitability (0%) |
Company | Industry |
---|---|---|
ROA (TTM) | -133.55% | N/A |
ROE (TTM) | -239.22% | N/A |
Net Profit Margin (TTM) | -217.20% | N/A |
ROIC 5YR AVG | -36.79% | N/A |
Growth (25%) |
4QTR AVG | 3YR AVG | 5YR AVG |
---|---|---|---|
EPS | -58.78% | -5,101.90% | -3,080.69% |
Revenue | -2.65% | 1,258.21% | 770.26% |
Net Income | -59.76% | -5,400.59% | -3,270.70% |
Cash Flow | 5.42% | -3,343.34% | -2,002.09% |
Health (25%) |
Company | Industry |
---|---|---|
Current Ratio (TTM) | 2.34 | N/A |
Quick Ratio (TTM) | 1.02 | N/A |
D/E Ratio (TTM) | 1.68 | N/A |
Interest Coverage (TTM) | -28.50 | N/A |
Piotroski F-Score | 2 | N/A |
Altman Z-Score | N/A | N/A |
LTL to 5YR AVG FCF | -1.18 | N/A |
Shares Outstanding Growth 5YR AVG | 180.57% | N/A |